Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic

Gastroenterol Hepatol (N Y). 2021 Jan;17(1):18-30.

Sheena Crosby 1, Michael J Schuh 1, Freddy Caldera 2, Francis A Farraye 3


Author information

  • 1Department of Pharmacy, Mayo Clinic, Jacksonville, Florida.
  • 2Department of Medicine, Division of Gastroenterology and Hepatology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.
  • 3Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida.


Inflammatory bowel disease and the subsequent immunosuppressive regimens used to treat this condition increase the risk for acquiring viral and bacterial infections. Ensuring that patients are up-to-date with their immunizations may help prevent the development of several of these vaccine-preventable diseases. Therefore, it is imperative that gastroenterology providers offer vaccinations to patients or direct vaccination guidance to primary care providers to minimize the risk for vaccine-preventable diseases. To decrease the risk for co-infection in the setting of the coronavirus disease 2019 pandemic and avoid placing any further burden on the health care system, the call to immunize is more important than ever.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.